| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $266.0M | — | -7.1% |
| Cost of Revenue | $182.4M | — | -10.5% |
| Gross Profit | $83.6M | — | +1.2% |
| R&D Expense | $10.7M | — | -23.6% |
| SG&A Expense | $26.6M | — | -27.1% |
| Operating Income | -$21.8M | — | +50.9% |
| Pre-tax Income | -$39.8M | — | +41.5% |
| Income Tax | -$988K | — | +92.5% |
| Net Income | -$38.8M | — | +29.3% |
| EPS (Basic) | -$0.40 | — | +42.9% |
| EPS (Diluted) | -$0.40 | — | +42.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $85.5M | -33.3% | -37.3% |
| Short-term Investments | $13.2M | +25.6% | -32.8% |
| Accounts Receivable | $278.8M | -18.6% | -15.1% |
| Current Assets | $426.0M | -19.7% | -20.2% |
| Total Assets | $1.20B | -9.5% | -28.8% |
| Current Liabilities | $409.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$34.9M | — | -3509.8% |
| Capital Expenditures | $726K | — | -75.1% |
| Investing Cash Flow | -$8.6M | — | +98.4% |
| Financing Cash Flow | -$136K | — | -100.0% |
| Free Cash Flow | -$35.6M | — | -815.8% |
| -13.4% |
| Long-term Debt | $606.2M | +0.2% | -0.8% |
| Total Liabilities | $1.15B | -6.6% | -5.1% |
| Stockholders' Equity | $50.3M | -47.3% | -89.4% |